NLRP3 and acute respiratory distress syndrome: Noteworthy, animal experiments have shown that MET can inhibit NLRP3 inflammasome activation by suppressing mitochondrial ATP and DNA synthesis, protecting mice against LPS-induced acute respiratory distress syndrome (ARDS) and attenuating pulmonary inflammation in COVID-19-infected mice25.